Distinct molecular pathways in ovarian endometrioid adenocarcinoma with concurrent endometriosis

dc.contributor.authorZhang, Chi
dc.contributor.authorWang, Xiyin
dc.contributor.authorAnaya, Yanett
dc.contributor.authorParodi, Luca
dc.contributor.authorCheng, Lijun
dc.contributor.authorAnderson, Matthew L.
dc.contributor.authorHawkins, Shannon M.
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2018-10-11T14:13:58Z
dc.date.available2018-10-11T14:13:58Z
dc.date.issued2018
dc.description.abstractWomen with endometriosis, a benign growth of endometrial tissue outside the uterine cavity, are at increased risk of specific histotypes of epithelial ovarian cancer, such as ovarian endometrioid adenocarcinoma (OEA). Women with OEA who have endometriosis at time of surgical staging demonstrate improved clinical prognosis compared to women with OEA without evidence of endometriosis. However, the molecular contributions of the endometriotic tumor microenvironment to these ovarian cancers remain poorly understood. As a starting point, we used a platform for genome‐wide transcriptomic profiling to compare specimens of OEA from women with and without concurrent endometriosis and benign reproductive tract tissues, including proliferative endometrium and typical and atypical endometrioma samples (n = 20). Principle component analysis revealed distinct clustering between benign and malignant samples as well as malignant samples with and without concurrent endometriosis. Examination of gene signatures revealed that OEA with concurrent endometriosis contained a unique molecular signature compared to OEA without concurrent endometriosis, distinguished by 682 unique genes differentially expressed (fold change < or >1.5, p < 0.01). Bioinformatic analysis of these differentially expressed gene products using ingenuity pathway analysis revealed activation of NFkB signaling, an inflammatory signaling pathway constitutively active in endometriosis. DAVID functional annotation clustering further revealed enrichment in RAS signaling as both cytoskeleton organization and GTPase regulator activity relied heavily on RAS protein signal transduction. Gene set enrichment analysis highlighted immune and inflammatory nodes involved in OEA with concurrent endometriosis. These observations provide novel resources for understanding molecular subtleties potentially involved in OEA within the context of the endometriotic tumor microenvironment.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationZhang, C., Wang, X., Anaya, Y., Parodi, L., Cheng, L., Anderson, M. L., & Hawkins, S. M. (2018). Distinct Molecular Pathways in Ovarian Endometrioid Adenocarcinoma with Concurrent Endometriosis. International Journal of Cancer, 0(ja). https://doi.org/10.1002/ijc.31768en_US
dc.identifier.urihttps://hdl.handle.net/1805/17498
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.isversionof10.1002/ijc.31768en_US
dc.relation.journalInternational Journal of Canceren_US
dc.rightsPublisher Policyen_US
dc.sourceAuthoren_US
dc.subjectovarian canceren_US
dc.subjectendometriosisen_US
dc.subjectmolecular pathwaysen_US
dc.titleDistinct molecular pathways in ovarian endometrioid adenocarcinoma with concurrent endometriosisen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Zhang_2018_distinct.pdf
Size:
745.05 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: